431 related articles for article (PubMed ID: 29687739)
1. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
van der Poest Clement EA; Sahin M; Peters JM
J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
Yum MS; Lee EH; Ko TS
J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
[TBL] [Abstract][Full Text] [Related]
3. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
4. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
[TBL] [Abstract][Full Text] [Related]
5. The Utility of Surveillance Electroencephalography to Guide Early Antiepileptic Drug Therapy in Infants With Tuberous Sclerosis Complex.
Whitney R; Jan S; Zak M; McCoy B
Pediatr Neurol; 2017 Jul; 72():76-80. PubMed ID: 28506505
[TBL] [Abstract][Full Text] [Related]
6. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
7. [Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis].
Rotta NT; da Silva AR; Ohlweiler L; Riesgo R
Arq Neuropsiquiatr; 2003 Dec; 61(4):988-90. PubMed ID: 14762603
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
Friedman D; Bogner M; Parker-Menzer K; Devinsky O
Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.
Kotulska K; Kwiatkowski DJ; Curatolo P; Weschke B; Riney K; Jansen F; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Sijko K; Głowacka-Walas J; Borkowska J; Sadowski K; Domańska-Pakieła D; Moavero R; Hertzberg C; Hulshof H; Scholl T; Benova B; Aronica E; de Ridder J; Lagae L; Jóźwiak S;
Ann Neurol; 2021 Feb; 89(2):304-314. PubMed ID: 33180985
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of vigabatrin therapy for tuberous sclerosis with infantile spasms].
Suzuki-Muromoto, S; Uematsu M; Sato H; Numata-Uematsu Y; Nakayama T; Kiluchi A; Kobayashi T; Hino-Fukuyo N; Kure S
No To Hattatsu; 2016 Nov; 48(6):413-9. PubMed ID: 30010289
[TBL] [Abstract][Full Text] [Related]
11. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
[TBL] [Abstract][Full Text] [Related]
12. Focal Epilepsy in Children With Tuberous Sclerosis Complex: Does Vigabatrin Control Focal Seizures?
Lin S; Liao J; Zhao X; Hu Y; Chen L; Chen Y; Liu G; Yao Y; Su Q; Scheffer IE; Wen F
J Child Neurol; 2022 Apr; 37(5):329-333. PubMed ID: 35321578
[TBL] [Abstract][Full Text] [Related]
13. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
Hancock E; Osborne JP
J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
[TBL] [Abstract][Full Text] [Related]
14. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
[TBL] [Abstract][Full Text] [Related]
15. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
[TBL] [Abstract][Full Text] [Related]
16. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
Prasad AN; Penney S; Buckley DJ
Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
Camposano SE; Major P; Halpern E; Thiele EA
Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
[TBL] [Abstract][Full Text] [Related]
18. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis.
Cusmai R; Moavero R; Bombardieri R; Vigevano F; Curatolo P
Epilepsy Behav; 2011 Dec; 22(4):735-9. PubMed ID: 22142783
[TBL] [Abstract][Full Text] [Related]
19. Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex.
Józwiak S; Domańska-Pakieła D; Kotulska K; Kaczorowska M
Epilepsia; 2007 Aug; 48(8):1632; author reply 1632-4. PubMed ID: 17692054
[No Abstract] [Full Text] [Related]
20. Preventive Antiepileptic Treatment in Tuberous Sclerosis Complex: A Long-Term, Prospective Trial.
Jozwiak S; Słowińska M; Borkowska J; Sadowski K; Łojszczyk B; Domańska-Pakieła D; Chmielewski D; Kaczorowska-Frontczak M; Głowacka J; Sijko K; Kotulska K
Pediatr Neurol; 2019 Dec; 101():18-25. PubMed ID: 31481332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
